Update on actinic keratosis in clinical trial experience with imiquimod

C. Ferrándiz

Research output: Contribution to journalReview articleResearchpeer-review

11 Citations (Scopus)

Abstract

Actinic keratoses (AK) is a sun induced cutaneous lesion, currently considered as a squamous cell carcinoma in situ that has the potential to progress to invasive SCC. To treat them, numerous, ablative and no ablative, therapeutic approaches exist. Among them, imiquimod, a toll like receptor agonist, recently approved to treat them in the US and Europe, has demonstrated to be effective and safe with an acceptable tolerability in the treatment of these lesions. In this article the results of several high quality RCT are analysed. © 2007 The Author.
Original languageEnglish
Pages (from-to)32-33
JournalBritish Journal of Dermatology
Volume157
Issue numberSUPPL. 2
DOIs
Publication statusPublished - 1 Dec 2007

Keywords

  • Actinic keratosis
  • Imiquimod

Fingerprint Dive into the research topics of 'Update on actinic keratosis in clinical trial experience with imiquimod'. Together they form a unique fingerprint.

Cite this